STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 16.38

+2.2%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WWS who wrote (218)	3/1/1999 12:18:00 AM
From: Mike McFarland	Read Replies (1) of 805

Thanks Bill, here is an older article from Scientific American sciam.com companies mentioned are... SyStemix--a division of Novartis StemCells, Inc.--now part of CytoTherapeutics Osiris Therapeutics--which Novartis partly owns Geron I finally rediscovered the quote from McCament (editor of the Medical Technology Stock Letter) "CytoTherapeutics is much closer to the clinic and more significant from an investment standpoint" (compared to Geron). Richard M. Rose, of ctii was quoted in the same article as saying "We're not talking about something 10 to 20 years away like Geron" (Businessweek 11/23/98). These Nature Biotechnology...Genetics...Medicine articles are pretty dense stuff for me...so I'll stick to pasting the fluffy stuff from mainstream mags for now. But I'll say...the Nature website is pretty nice...did not even have to go to the library to borrow the photocopy key--a modem and a decent printer, and voila!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next